Teprasiran sodium is a small interfering RNA (siRNA) therapeutic that harnesses the mechanism of RNA interference (RNAi) to target and silence specific messenger RNA (mRNA) sequences responsible for the production of disease-related proteins. By binding to these mRNA molecules, it induces their degradation and prevents the synthesis of pathogenic proteins, thus interrupting the disease process at a molecular level.
Chemical Structure:
